Lv4
528 积分 2020-07-19 加入
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
4小时前
待确认
Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis
13小时前
待确认
Tirzepatide and the prevention of heart failure in obesity: a multi-center cohort study using the TriNetX database
13小时前
求助中
Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial
13小时前
求助中
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes
29天前
已关闭
Obesity drugs made in China could power next wave of treatments
1个月前
已完结
The evolution of the obesity drug market
1个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
1个月前
已关闭
Understanding the cause of type 2 diabetes
1个月前
已完结
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme
1个月前
已完结
皖公网安备34019202002308
